<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>6817566</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">31695670</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">6817566</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.3389/fneur.2019.01114</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>Table 1</table-label><table-caption>Demographic and clinical features in baseline measurement.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" position="float"><label>Table 1</label><caption><p>Demographic and clinical features in baseline measurement.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"><bold>Acupuncture</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Control</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Significance</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Number of patients</td><td valign="top" align="center" rowspan="1" colspan="1">9</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Age</td><td valign="top" align="center" rowspan="1" colspan="1">60.7 ± 6.3</td><td valign="top" align="center" rowspan="1" colspan="1">70.4 ± 8.2</td><td valign="top" align="center" rowspan="1" colspan="1"><italic>P</italic> = 0.042</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Gender (M/F)</td><td valign="top" align="center" rowspan="1" colspan="1">4/5</td><td valign="top" align="center" rowspan="1" colspan="1">5/2</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Years of disease</td><td valign="top" align="center" rowspan="1" colspan="1">9.4 ± 4.1</td><td valign="top" align="center" rowspan="1" colspan="1">9.7 ± 5.4</td><td valign="top" align="center" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">LEDD</td><td valign="top" align="center" rowspan="1" colspan="1">708 ± 311.6</td><td valign="top" align="center" rowspan="1" colspan="1">732 ± 370.6</td><td valign="top" align="center" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1"><bold>Disease-specific assessment</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">UPDRS Total</td><td valign="top" align="center" rowspan="1" colspan="1">35.7 ± 14.2</td><td valign="top" align="center" rowspan="1" colspan="1">36.6 ± 11.8</td><td valign="top" align="center" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">UPDRS I</td><td valign="top" align="center" rowspan="1" colspan="1">2.0 ± 1.7</td><td valign="top" align="center" rowspan="1" colspan="1">2.9 ± 1.8</td><td valign="top" align="center" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">UPDRS II</td><td valign="top" align="center" rowspan="1" colspan="1">10.8 ± 4.4</td><td valign="top" align="center" rowspan="1" colspan="1">11.7 ± 5.4</td><td valign="top" align="center" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">UPDRS III</td><td valign="top" align="center" rowspan="1" colspan="1">18.2 ± 5.5</td><td valign="top" align="center" rowspan="1" colspan="1">20 ± 5</td><td valign="top" align="center" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">UPDRS IV</td><td valign="top" align="center" rowspan="1" colspan="1">4.7 ± 5.1</td><td valign="top" align="center" rowspan="1" colspan="1">2.0 ± 2.6</td><td valign="top" align="center" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1"><bold>Cognitive and psychological assessment</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BDI-II</td><td valign="top" align="center" rowspan="1" colspan="1">9.2 ± 5.5</td><td valign="top" align="center" rowspan="1" colspan="1">11.1 ± 5.0</td><td valign="top" align="center" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PDSS-2</td><td valign="top" align="center" rowspan="1" colspan="1">15.7 ± 9.3</td><td valign="top" align="center" rowspan="1" colspan="1">8.9 ± 4</td><td valign="top" align="center" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PDQ-39</td><td valign="top" align="center" rowspan="1" colspan="1">30.8 ± 18.4</td><td valign="top" align="center" rowspan="1" colspan="1">31.3 ± 14.5</td><td valign="top" align="center" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MMSE</td><td valign="top" align="center" rowspan="1" colspan="1">28.4 ± 1.3</td><td valign="top" align="center" rowspan="1" colspan="1">26.6 ± 2.2</td><td valign="top" align="center" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">VAS</td><td valign="top" align="center" rowspan="1" colspan="1">5.3 ± 2.6</td><td valign="top" align="center" rowspan="1" colspan="1">5.1 ± 3.0</td><td valign="top" align="center" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">KPPS</td><td valign="top" align="center" rowspan="1" colspan="1">21.9 ± 19.8</td><td valign="top" align="center" rowspan="1" colspan="1">7.1 ± 5.4</td><td valign="top" align="center" rowspan="1" colspan="1">NS</td></tr></tbody></table><table-wrap-foot><p><italic>LEDD, Levodopa Equivalent Dose; UPDRS, Unified Parkinson's Disease Rating Scale; BDI-II, Beck Depression Inventory II; PDSS, Parkinson's Disease Sleep Scale; PDQ, Parkinson's Disease Questionnaire; MMSE, Mini-Mental State Examination; VAS, visual analog scale; KPPS, King's Parkinson's Disease Pain Scale; NS, No significance</italic>.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic and clinical features in baseline measurement.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th/><th valign="top" align="center">Acupuncture</th><th valign="top" align="center">Control</th><th valign="top" align="center">Significance</th></tr></thead><tbody><tr><td valign="top" align="left">Number of patients</td><td valign="top" align="center">9</td><td valign="top" align="center">7</td><td/></tr><tr><td valign="top" align="left">Age</td><td valign="top" align="center">60.7 ± 6.3</td><td valign="top" align="center">70.4 ± 8.2</td><td valign="top" align="center">P = 0.042</td></tr><tr><td valign="top" align="left">Gender (M/F)</td><td valign="top" align="center">4/5</td><td valign="top" align="center">5/2</td><td/></tr><tr><td valign="top" align="left">Years of disease</td><td valign="top" align="center">9.4 ± 4.1</td><td valign="top" align="center">9.7 ± 5.4</td><td valign="top" align="center">NS</td></tr><tr><td valign="top" align="left">LEDD</td><td valign="top" align="center">708 ± 311.6</td><td valign="top" align="center">732 ± 370.6</td><td valign="top" align="center">NS</td></tr><tr><td valign="top" align="left" colspan="4">Disease-specific assessment</td></tr><tr><td valign="top" align="left">UPDRS Total</td><td valign="top" align="center">35.7 ± 14.2</td><td valign="top" align="center">36.6 ± 11.8</td><td valign="top" align="center">NS</td></tr><tr><td valign="top" align="left">UPDRS I</td><td valign="top" align="center">2.0 ± 1.7</td><td valign="top" align="center">2.9 ± 1.8</td><td valign="top" align="center">NS</td></tr><tr><td valign="top" align="left">UPDRS II</td><td valign="top" align="center">10.8 ± 4.4</td><td valign="top" align="center">11.7 ± 5.4</td><td valign="top" align="center">NS</td></tr><tr><td valign="top" align="left">UPDRS III</td><td valign="top" align="center">18.2 ± 5.5</td><td valign="top" align="center">20 ± 5</td><td valign="top" align="center">NS</td></tr><tr><td valign="top" align="left">UPDRS IV</td><td valign="top" align="center">4.7 ± 5.1</td><td valign="top" align="center">2.0 ± 2.6</td><td valign="top" align="center">NS</td></tr><tr><td valign="top" align="left" colspan="4">Cognitive and psychological assessment</td></tr><tr><td valign="top" align="left">BDI-II</td><td valign="top" align="center">9.2 ± 5.5</td><td valign="top" align="center">11.1 ± 5.0</td><td valign="top" align="center">NS</td></tr><tr><td valign="top" align="left">PDSS-2</td><td valign="top" align="center">15.7 ± 9.3</td><td valign="top" align="center">8.9 ± 4</td><td valign="top" align="center">NS</td></tr><tr><td valign="top" align="left">PDQ-39</td><td valign="top" align="center">30.8 ± 18.4</td><td valign="top" align="center">31.3 ± 14.5</td><td valign="top" align="center">NS</td></tr><tr><td valign="top" align="left">MMSE</td><td valign="top" align="center">28.4 ± 1.3</td><td valign="top" align="center">26.6 ± 2.2</td><td valign="top" align="center">NS</td></tr><tr><td valign="top" align="left">VAS</td><td valign="top" align="center">5.3 ± 2.6</td><td valign="top" align="center">5.1 ± 3.0</td><td valign="top" align="center">NS</td></tr><tr><td valign="top" align="left">KPPS</td><td valign="top" align="center">21.9 ± 19.8</td><td valign="top" align="center">7.1 ± 5.4</td><td valign="top" align="center">NS</td></tr></tbody></table></div>LEDD, Levodopa Equivalent Dose; UPDRS, Unified Parkinson's Disease Rating Scale; BDI-II, Beck Depression Inventory II; PDSS, Parkinson's Disease Sleep Scale; PDQ, Parkinson's Disease Questionnaire; MMSE, Mini-Mental State Examination; VAS, visual analog scale; KPPS, King's Parkinson's Disease Pain Scale; NS, No significance.</transformed-table></extracted-table><extracted-table><table-id>T2</table-id><table-label>Table 2</table-label><table-caption>Changes of clinical features between baseline and post-treatment.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T2" position="float"><label>Table 2</label><caption><p>Changes of clinical features between baseline and post-treatment.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"><bold>Acupuncture</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Control</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Significance</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">UPDRS Total</td><td valign="top" align="center" rowspan="1" colspan="1">−7.7 ± 4.5</td><td valign="top" align="center" rowspan="1" colspan="1">0.7 ± 4.9</td><td valign="top" align="center" rowspan="1" colspan="1"><italic>P</italic> = 0.005</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">UPDRS I</td><td valign="top" align="center" rowspan="1" colspan="1">−0.1 ± 1.3</td><td valign="top" align="center" rowspan="1" colspan="1">0.3 ± 2.3</td><td valign="top" align="center" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">UPDRS II</td><td valign="top" align="center" rowspan="1" colspan="1">−2.6 ± 2.0</td><td valign="top" align="center" rowspan="1" colspan="1">−0.7 ± 1.0</td><td valign="top" align="center" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">UPDRS III</td><td valign="top" align="center" rowspan="1" colspan="1">−4.1 ± 4.0</td><td valign="top" align="center" rowspan="1" colspan="1">0.0 ± 3.8</td><td valign="top" align="center" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">UPDRS IV</td><td valign="top" align="center" rowspan="1" colspan="1">−0.9 ± 2.0</td><td valign="top" align="center" rowspan="1" colspan="1">1.1 ± 2.0</td><td valign="top" align="center" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BDI-II</td><td valign="top" align="center" rowspan="1" colspan="1">1.1 ± 8.8</td><td valign="top" align="center" rowspan="1" colspan="1">0.7 ± 8.0</td><td valign="top" align="center" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PDSS-2</td><td valign="top" align="center" rowspan="1" colspan="1">−1.1 ± 6.8</td><td valign="top" align="center" rowspan="1" colspan="1">1.9 ± 5.2</td><td valign="top" align="center" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PDQ-39</td><td valign="top" align="center" rowspan="1" colspan="1">−5.9 ± 13.4</td><td valign="top" align="center" rowspan="1" colspan="1">4.1 ± 10.0</td><td valign="top" align="center" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MMSE</td><td valign="top" align="center" rowspan="1" colspan="1">−0.1 ± 1.5</td><td valign="top" align="center" rowspan="1" colspan="1">0.4 ± 1.3</td><td valign="top" align="center" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">VAS</td><td valign="top" align="center" rowspan="1" colspan="1">−0.7 ± 2.3</td><td valign="top" align="center" rowspan="1" colspan="1">−0.1 ± 3.6</td><td valign="top" align="center" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">KPPS</td><td valign="top" align="center" rowspan="1" colspan="1">−10.1 ± 8.0</td><td valign="top" align="center" rowspan="1" colspan="1">1.6 ± 9.6</td><td valign="top" align="center" rowspan="1" colspan="1"><italic>P</italic> = 0.023</td></tr></tbody></table><table-wrap-foot><p><italic>LEDD, Levodopa Equivalent Dose; UPDRS, Unified Parkinson's Disease Rating Scale; BDI-II, Beck Depression Inventory II; PDSS, Parkinson's Disease Sleep Scale; PDQ, Parkinson's Disease Questionnaire; MMSE, Mini-Mental State Examination; VAS, visual analog scale; KPPS, King's Parkinson's Disease Pain Scale; NS, No significance. The data were expressed as (Mean ± SD)</italic>.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Changes of clinical features between baseline and post-treatment.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th/><th valign="top" align="center">Acupuncture</th><th valign="top" align="center">Control</th><th valign="top" align="center">Significance</th></tr></thead><tbody><tr><td valign="top" align="left">UPDRS Total</td><td valign="top" align="center">−7.7 ± 4.5</td><td valign="top" align="center">0.7 ± 4.9</td><td valign="top" align="center">P = 0.005</td></tr><tr><td valign="top" align="left">UPDRS I</td><td valign="top" align="center">−0.1 ± 1.3</td><td valign="top" align="center">0.3 ± 2.3</td><td valign="top" align="center">NS</td></tr><tr><td valign="top" align="left">UPDRS II</td><td valign="top" align="center">−2.6 ± 2.0</td><td valign="top" align="center">−0.7 ± 1.0</td><td valign="top" align="center">NS</td></tr><tr><td valign="top" align="left">UPDRS III</td><td valign="top" align="center">−4.1 ± 4.0</td><td valign="top" align="center">0.0 ± 3.8</td><td valign="top" align="center">NS</td></tr><tr><td valign="top" align="left">UPDRS IV</td><td valign="top" align="center">−0.9 ± 2.0</td><td valign="top" align="center">1.1 ± 2.0</td><td valign="top" align="center">NS</td></tr><tr><td valign="top" align="left">BDI-II</td><td valign="top" align="center">1.1 ± 8.8</td><td valign="top" align="center">0.7 ± 8.0</td><td valign="top" align="center">NS</td></tr><tr><td valign="top" align="left">PDSS-2</td><td valign="top" align="center">−1.1 ± 6.8</td><td valign="top" align="center">1.9 ± 5.2</td><td valign="top" align="center">NS</td></tr><tr><td valign="top" align="left">PDQ-39</td><td valign="top" align="center">−5.9 ± 13.4</td><td valign="top" align="center">4.1 ± 10.0</td><td valign="top" align="center">NS</td></tr><tr><td valign="top" align="left">MMSE</td><td valign="top" align="center">−0.1 ± 1.5</td><td valign="top" align="center">0.4 ± 1.3</td><td valign="top" align="center">NS</td></tr><tr><td valign="top" align="left">VAS</td><td valign="top" align="center">−0.7 ± 2.3</td><td valign="top" align="center">−0.1 ± 3.6</td><td valign="top" align="center">NS</td></tr><tr><td valign="top" align="left">KPPS</td><td valign="top" align="center">−10.1 ± 8.0</td><td valign="top" align="center">1.6 ± 9.6</td><td valign="top" align="center">P = 0.023</td></tr></tbody></table></div>LEDD, Levodopa Equivalent Dose; UPDRS, Unified Parkinson's Disease Rating Scale; BDI-II, Beck Depression Inventory II; PDSS, Parkinson's Disease Sleep Scale; PDQ, Parkinson's Disease Questionnaire; MMSE, Mini-Mental State Examination; VAS, visual analog scale; KPPS, King's Parkinson's Disease Pain Scale; NS, No significance. The data were expressed as (Mean ± SD).</transformed-table></extracted-table><extracted-table><table-id>T3</table-id><table-label>Table 3</table-label><table-caption>Significant correlations between changes in King's Parkinson's Disease Pain Scale scores (overall and for subdomains) and functional connectivity.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T3" position="float"><label>Table 3</label><caption><p>Significant correlations between changes in King's Parkinson's Disease Pain Scale scores (overall and for subdomains) and functional connectivity.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"><bold><italic>P</italic>-value</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>R</bold></th></tr></thead><tbody><tr><td valign="top" align="left" colspan="3" rowspan="1"><bold>Total score</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Right precentral gyrus, left middle frontal gyrus</td><td valign="top" align="center" rowspan="1" colspan="1">0.037</td><td valign="top" align="center" rowspan="1" colspan="1">−0.698</td></tr><tr><td valign="top" align="left" colspan="3" rowspan="1"><bold>Subdomain 1 (musculoskeletal pain)</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Right posterior cingulate gyrus, right lobule IX of cerebellar hemisphere</td><td valign="top" align="center" rowspan="1" colspan="1">0.000</td><td valign="top" align="center" rowspan="1" colspan="1">0.932</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Right caudate nucleus, right transverse temporal gyrus</td><td valign="top" align="center" rowspan="1" colspan="1">0.000</td><td valign="top" align="center" rowspan="1" colspan="1">0.932</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Left crus II of cerebellar hemisphere, right lobule IX of cerebellar hemisphere</td><td valign="top" align="center" rowspan="1" colspan="1">0.000</td><td valign="top" align="center" rowspan="1" colspan="1">0.932</td></tr><tr><td valign="top" align="left" colspan="3" rowspan="1"><bold>Subdomain 4 (nocturnal pain)</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Right precentral gyrus, right medial orbitofrontal cortex</td><td valign="top" align="center" rowspan="1" colspan="1">0.000</td><td valign="top" align="center" rowspan="1" colspan="1">−0.953</td></tr><tr><td valign="top" align="left" colspan="3" rowspan="1"><bold>Subdomain 7 (radicular pain)</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Right parahippocampal gyrus, left lobule VI of cerebellar hemisphere</td><td valign="top" align="center" rowspan="1" colspan="1">0.015</td><td valign="top" align="center" rowspan="1" colspan="1">−0.772</td></tr></tbody></table></table-wrap></original-table><transformed-table>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Significant correlations between changes in King's Parkinson's Disease Pain Scale scores (overall and for subdomains) and functional connectivity.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th/><th valign="top" align="center">P-value</th><th valign="top" align="center">R</th></tr></thead><tbody><tr><td valign="top" align="left" colspan="3">Total score</td></tr><tr><td valign="top" align="left">Right precentral gyrus, left middle frontal gyrus</td><td valign="top" align="center">0.037</td><td valign="top" align="center">−0.698</td></tr><tr><td valign="top" align="left" colspan="3">Subdomain 1 (musculoskeletal pain)</td></tr><tr><td valign="top" align="left">Right posterior cingulate gyrus, right lobule IX of cerebellar hemisphere</td><td valign="top" align="center">0.000</td><td valign="top" align="center">0.932</td></tr><tr><td valign="top" align="left">Right caudate nucleus, right transverse temporal gyrus</td><td valign="top" align="center">0.000</td><td valign="top" align="center">0.932</td></tr><tr><td valign="top" align="left">Left crus II of cerebellar hemisphere, right lobule IX of cerebellar hemisphere</td><td valign="top" align="center">0.000</td><td valign="top" align="center">0.932</td></tr><tr><td valign="top" align="left" colspan="3">Subdomain 4 (nocturnal pain)</td></tr><tr><td valign="top" align="left">Right precentral gyrus, right medial orbitofrontal cortex</td><td valign="top" align="center">0.000</td><td valign="top" align="center">−0.953</td></tr><tr><td valign="top" align="left" colspan="3">Subdomain 7 (radicular pain)</td></tr><tr><td valign="top" align="left">Right parahippocampal gyrus, left lobule VI of cerebellar hemisphere</td><td valign="top" align="center">0.015</td><td valign="top" align="center">−0.772</td></tr></tbody></table></div></transformed-table></extracted-table></extracted-tables-set>